We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
Publication, Part of National Diabetes Audit
National Diabetes Audit, Non-Diabetic Hyperglycaemia, 2019- 2020, Diabetes Prevention Programme, Data Release
Audit,- Publication Date:
- 19 Nov 2020
- Geographic Coverage:
- England
- Geographical Granularity:
- Clinical Commissioning Groups, GP practices
- Date Range:
- 01 Jan 2019 to 31 Mar 2020
Summary
The NHS Diabetes Prevention Programme (NHS DPP) is a joint commitment from NHS England, Public Health England and Diabetes UK to deliver, at scale, evidence based behavioural interventions that can prevent or delay the onset of Type 2 diabetes in adults who have been identified as having non-diabetic hyperglycaemia.
This short report uses data collected from GP practices alongside the National Diabetes Audit (NDA) for the period January 2019 to March 2020 inclusive. This report is for England only. Unlike the NDA, it does not include information on Wales. This short report details the top-level findings for the period 2019-20 audit. Further reporting will follow during 2021.
Key Facts
- Non-diabetic hyperglycaemia refers to blood glucose levels that are above normal but not in the diabetic range (HbA1c 42-47 mmol/mol (6.0-6.4%) or fasting plasma glucose 5.5-6.9 mmol/l).
- People with non-diabetic hyperglycaemia are at increased risk of developing Type 2 diabetes. They are also at increased risk of other cardiovascular conditions.
- 2.1 million people in England were recorded as having non-diabetic hyperglycaemia for the period January 2019 to March 2020. This is an increase from 1.8 million in 2018-19. The difference is most likely due to an increase in the recording of the diagnosis during 2019-20.
Resources
Last edited: 18 November 2020 4:19 pm